Skip to Content
 

VICC toll-free number 1-877-936-8422

Clinical Trials for Thyroid Cancer

2 Open Trials

    Trial Type Protocol No. &
    Open Date
    Summary

    Treatment

    VICCMD15107

    11/07/2017

    A Phase 1/2a Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of PLX8394 in Patients with Advanced, Unresectable Solid Tumors

    Treatment

    VICCMD15110

    04/05/2016

    A Phase II Basket Study of the Oral TRK Inhibitor LOXO-101 in Subjects with NTRK Fusion-Positive Tumors


    Print this page for your doctor